Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Commentary
Cardio Oncology with ACOS
Case Report
Case Series
Conference Review
Consensus Statement
Current Issue
Editorial
Erratum
Letter to Editor
New Drug Update
News
Original Article
Position Paper
Response to the letter
Review Article
Short Communication

Most Viewed Articles


Articles Fulltext downloads PDF downloads Total downloads
Short Communication
Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI:10.25259/IJMIO_30_2020
13,727 1,366 15,093
Short Communication
Driver mutations in oncogenesis
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI:10.25259/IJMIO_26_2020
12,058 736 12,794
Case Report
Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_16_2021
12,119 97 12,216
New Drug Update
Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_13_2021
11,719 120 11,839
News
Editorial board tribute to Dr. Amit Verma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
11,097 110 11,207
Review Article
Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI:10.25259/IJMIO_8_2022
9,043 2,081 11,124
Case Report
Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI:10.25259/IJMIO_5_2022
8,394 2,573 10,967
Original Article
Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI:10.25259/IJMIO_2_2022
8,843 2,016 10,859
Cardio Oncology with ACOS
Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI:10.25259/IJMIO_1_2022
8,700 2,083 10,783
Erratum
Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, October
DOI:10.25259/IJMIO_05_2020_ER
10,364 72 10,436
Review Article
Immune dynamics of SARS-CoV-2 virus evolution
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI:10.25259/IJMIO_26_2021
8,462 1,814 10,276
Editorial
Nanobytes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_7_2019
5,429 4,714 10,143
Conference Review
6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_20_2021
9,836 170 10,006
Case Series
Dual driver in non-small cell lung carcinoma – therapeutic dilemma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI:10.25259/IJMIO_22_2021
9,789 197 9,986
Review Article
The evolving role of precision medicine in the management of advanced sarcomas – A mini review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_6_2021
9,413 191 9,604
Review Article
Immuno-oncology of differentiated thyroid cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI:10.25259/IJMIO_36_2020
8,078 1,150 9,228
Review Article
A compendium of population wide DNA methylation profile for oral cancer in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI:10.25259/IJMIO_2_2021
7,755 1,384 9,139
Review Article
Immuno-oncological era of breast cancer: A progressive path to better treatment
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI:10.25259/IJMIO_3_2022
6,951 2,153 9,104
Brief Commentary
ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_10_2021
8,853 88 8,941
Case Report
Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI:10.25259/IJMIO_18_2021
8,781 106 8,887
Review Article
Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_12_2021
8,708 124 8,832
Case Report
Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI:10.25259/IJMIO_11_2022
8,139 563 8,702
Brief Commentary
Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_7_2021
8,135 305 8,440
Original Article
Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_1_2019
3,960 3,965 7,925
Review Article
Is continuous infusion of high-dose ifosfamide, a safe option? Drug review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI:10.25259/IJMIO_21_2019
6,430 1,479 7,909